Cargando…
Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
Autores principales: | Mahler, Donald A., Ohar, Jill A., Ferguson, Gary T., Donohue, James F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667917/ https://www.ncbi.nlm.nih.gov/pubmed/32791005 http://dx.doi.org/10.1164/rccm.202004-1489LE |
Ejemplares similares
-
Reply to Mahler et al.: Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Nici, Linda, et al.
Publicado: (2020) -
Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019) -
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
por: Ohar, Jill A, et al.
Publicado: (2022) -
Health-related quality of life and chronic obstructive pulmonary disease in North Carolina
por: Brown, David W., et al.
Publicado: (2010) -
Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A., et al.
Publicado: (2023)